Dupilumab Improves AD Affecting the Hands, Feet

Dupilumab monotherapy was an effective and safe systemic treatment for patients with moderate to severe hand and foot atopic dermatitis.

Related Keywords

Oregon ,United States ,American ,Ericl Simpson , ,Oregon Health Science University In Portland ,Journal Of The American Academy Dermatology ,Foot Investigator ,Global Assessment ,Peak Pruritus Numeric Rating Scale ,Oregon Health ,Science University ,American Academy ,Dermatitis ,Hands ,Foot ,Feet ,Atopic Dermatitis ,Atopic Eczema ,Adolescent Medicine ,Teens ,Eenage ,Teenager ,Adolescent Health ,Adolescents ,Adolescent ,Quality Of Life ,Pol ,Ealth Related Quality Of Life ,Rqol ,Pruritus ,Pruritis ,Pitch ,Sleep ,Pain Management ,Allergic Contact Dermatitis ,Contact Dermatitis ,Eczema ,Spain ,